{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T02:38:45Z","timestamp":1789958325623,"version":"4.0.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,1,18]],"date-time":"2020-01-18T00:00:00Z","timestamp":1579305600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,1,18]],"date-time":"2020-01-18T00:00:00Z","timestamp":1579305600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100015763","name":"University of Szeged","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100015763","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pathol. Oncol. Res."],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1007\/s12253-019-00792-0","type":"journal-article","created":{"date-parts":[[2020,1,18]],"date-time":"2020-01-18T09:02:42Z","timestamp":1579338162000},"page":"2123-2133","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Clinicopathological Findings on 28 Cases with XP11.2 Renal Cell Carcinoma"],"prefix":"10.1007","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9247-6679","authenticated-orcid":false,"given":"Levente","family":"Kuthi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1ron","family":"Somor\u00e1cz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tam\u00e1s","family":"Micsik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Jenei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrienn","family":"Hajdu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Istv\u00e1n","family":"Sejben","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D\u00e1niel","family":"Imre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bogl\u00e1rka","family":"P\u00f3sfai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katalin","family":"K\u00f3czi\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D\u00e1vid","family":"Semj\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zolt\u00e1n","family":"Bajory","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janina","family":"Kulka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e9la","family":"Iv\u00e1nyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,1,18]]},"reference":[{"key":"792_CR1","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.cll.2005.01.008","volume":"25","author":"P Argani","year":"2005","unstructured":"Argani P, Faria M (2005) Translocation carcinomas of the kidney. Clin Lab Med 25:363\u2013378","journal-title":"Clin Lab Med"},{"key":"792_CR2","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/S0002-9440(10)61684-7","volume":"159","author":"P Argani","year":"2001","unstructured":"Argani P, Antonescu CR, Illei PB et al (2001) Primary renal neoplasms with the ASPL-TFE3 gene fusion of alveolar soft part sarcoma: a distinctive tumor entity previously included among renal cell carcinomas of children and adolescents. Am J Pathol 159:179\u2013192","journal-title":"Am J Pathol"},{"key":"792_CR3","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1093\/hmg\/5.9.1333","volume":"5","author":"SK Sidhar","year":"1996","unstructured":"Sidhar SK, Clark J, Gill S et al (1996) The t(X;1)(p11.2;q21.2) translocation in papillary renal cell carcinoma fuses a novel gene PRCC to the TFE3 transcription factor gene. Hum Mol Genet 5:1333\u20131338","journal-title":"Hum Mol Genet"},{"key":"792_CR4","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.1038\/sj.onc.1201394","volume":"15","author":"J Clark","year":"1997","unstructured":"Clark J, Lu YJ, Sidhar SK et al (1997) Fusion of splicing factor genes PSF and NonO (p54nrb) to the TFE3 gene in papillary renal cell carcinoma. Oncogene 15:2233\u20132239","journal-title":"Oncogene"},{"key":"792_CR5","doi-asserted-by":"publisher","first-page":"5374","DOI":"10.1038\/sj.onc.1206686","volume":"22","author":"P Argani","year":"2003","unstructured":"Argani P, Lui MY, Couturier J et al (2003) A novel CLTC-TFE3 gene fusion in pediatric renal adenocarcinoma with t(X;17)(p11.2;q23). Oncogene 22:5374\u20135378","journal-title":"Oncogene"},{"key":"792_CR6","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1097\/PAS.0b013e318031ffff","volume":"31","author":"P Argani","year":"2007","unstructured":"Argani P, Olgac S, Tickoo SK et al (2007) Xp11 translocation renal cell carcinoma in adults: expanded clinical, pathologic and genetic spectrum. Am J Surg Pathol 31:1149\u20131160","journal-title":"Am J Surg Pathol"},{"key":"792_CR7","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1097\/PAS.0b013e31824f24a6","volume":"36","author":"M Zhong","year":"2012","unstructured":"Zhong M, De Angelo P, Osborne L et al (2012) Translocation renal cell carcinomas in adults: a single-institution experience. Am J Surg Pathol 36:654\u2013662","journal-title":"Am J Surg Pathol"},{"key":"792_CR8","doi-asserted-by":"crossref","unstructured":"Qu Y, Gu C, Wang H et al. (2016) Diagnosis of adults Xp11.2 translocation renal cell carcinoma by immunohistochemistry and FISH assays: clinicopathological data from ethnic Chinese population. Sci rep 6:2167","DOI":"10.1038\/srep21677"},{"key":"792_CR9","doi-asserted-by":"crossref","first-page":"124","DOI":"10.5858\/2008-0391-RSR.1","volume":"134","author":"HB Armah","year":"2010","unstructured":"Armah HB, Parwani AV (2010) Xp11.2 translocation renal cell carcinoma. Arch Pathol Lab Med 134:124\u2013129","journal-title":"Arch Pathol Lab Med"},{"key":"792_CR10","first-page":"33","volume-title":"Moch H","author":"P Argani","year":"2016","unstructured":"Argani P, Cheville J, Ladanyi M (2016) MiT family translocation renal cell carcinomas. In: Humphrey PA, Ulbright TM, Reuter VE (eds) Moch H. Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs. IARCC Press Lyon, WHO Classification of Tumours, pp 33\u201334"},{"key":"792_CR11","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1097\/PAS.0b013e3181e8ce5b","volume":"34","author":"P Argani","year":"2010","unstructured":"Argani P, Hicks J, De Marzo AM et al (2010) Xp11 translocation renal cell carcinoma (RCC): extended Immunohistochemical profile emphasizing novel RCC markers. Am J Surg Pathol 34:1295\u20131303","journal-title":"Am J Surg Pathol"},{"key":"792_CR12","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1038\/modpathol.2011.93","volume":"24","author":"G Martignoni","year":"2011","unstructured":"Martignoni G, Gobbo S, Camparo P et al (2011) Differential expression of cathepsin K in neoplasms harboring TFE3 gene fusions. Mod Pathol 24:1313\u20131319","journal-title":"Mod Pathol"},{"key":"792_CR13","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1097\/PAS.0b013e31827e17cb","volume":"37","author":"Q Rao","year":"2013","unstructured":"Rao Q, Williamson SR, Zhang S et al (2013) TFE3 break-apart FISH has a higher sensitivity for Xp11.2 translocation-associated renal cell carcinoma compared with TFE3 or cathepsin K immunohistochemical staining alone: expanding the morphologic spectrum. Am J Surg Pathol 37:804\u2013815","journal-title":"Am J Surg Pathol"},{"key":"792_CR14","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1097\/PAS.0b013e3181609914","volume":"32","author":"P Camparo","year":"2008","unstructured":"Camparo P, Vasiliu V, Molinie V et al (2008) Renal translocation carcinomas: clinicopathologic, immunohistochemical, and gene expression profiling analysis of 31 cases with a review of the literature. Am J Surg Pathol 32:656\u2013670","journal-title":"Am J Surg Pathol"},{"key":"792_CR15","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1200\/JCO.2005.04.4693","volume":"24","author":"P Argani","year":"2006","unstructured":"Argani P, La\u00e9 M, Ballard ET et al (2006) Translocation carcinomas of the kidney after chemotherapy in childhood. J Clin Oncol 24:1529\u20131534","journal-title":"J Clin Oncol"},{"key":"792_CR16","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1093\/annonc\/mdq029","volume":"21","author":"GG Malouf","year":"2010","unstructured":"Malouf GG, Camparo P, Oudard S et al (2010) Targeted agents in metastatic Xp11 translocation\/TFE3 gene fusion renal cell carcinoma (RCC): a report from the juvenile RCC network. Ann Oncol 21:1834\u20131838","journal-title":"Ann Oncol"},{"key":"792_CR17","doi-asserted-by":"publisher","first-page":"5219","DOI":"10.1002\/cncr.25512","volume":"116","author":"TK Choueiri","year":"2010","unstructured":"Choueiri TK, Lim ZD, Hirsch MS et al (2010) Vascular endothelial growth factor-targeted therapy for the treatment of adult metastatic Xp11.2 translocation renal cell carcinoma. Cancer 116:5219\u20135225","journal-title":"Cancer"},{"key":"792_CR18","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1097\/00000478-200212000-00003","volume":"26","author":"P Argani","year":"2002","unstructured":"Argani P, Antonescu CR, Couturier J et al (2002) PRCC-TFE3 renal carcinomas: morphologic, immunohistochemical, ultrastructural, and molecular analysis of an entity associated with the t(X;1)(p11.2;q21). Am J Surg Pathol 26:1553\u20131566","journal-title":"Am J Surg Pathol"},{"key":"792_CR19","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1007\/s12253-016-0179-x","volume":"23","author":"L Kuthi","year":"2017","unstructured":"Kuthi L, Jenei A, Hajdu A et al (2017) Prognostic factors for renal cell carcinoma subtypes diagnosed according to the 2016 WHO renal tumor classification: a study involving 928 patients. Pathol Oncol Res 23:689\u2013698","journal-title":"Pathol Oncol Res"},{"key":"792_CR20","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1097\/PAS.0b013e318270f71c","volume":"37","author":"B Delahunt","year":"2013","unstructured":"Delahunt B, McKenney JK, Lohse CM et al (2013) A novel grading system for clear cell renal cell carcinoma incorporating tumor necrosis. Am J Surg Pathol 37:311\u2013322","journal-title":"Am J Surg Pathol"},{"key":"792_CR21","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.cll.2005.01.008","volume":"25","author":"P Argani","year":"2005","unstructured":"Argani P, Ladanyi M (2005) Translocation carcinomas of the kidney. Clin Lab Med 25:363\u2013378","journal-title":"Clin Lab Med"},{"key":"792_CR22","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1158\/1078-0432.CCR-08-1183","volume":"15","author":"Y Komai","year":"2009","unstructured":"Komai Y, Fujiwara M, Fujii Y et al (2009) Adult Xp11 translocation renal cell carcinoma diagnosed by cytogenetics and immunohistochemistry. Clin Cancer Res 15:1170\u20131176","journal-title":"Clin Cancer Res"},{"key":"792_CR23","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1038\/modpathol.2013.208","volume":"27","author":"CL Ellis","year":"2014","unstructured":"Ellis CL, Eble JN, Subhawong AP et al (2014) Clinical heterogeneity of Xp11 translocation renal cell carcinoma: impact of fusion subtype, age, and stage. Mod Pathol 27:875\u2013886","journal-title":"Mod Pathol"},{"key":"792_CR24","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1097\/00000478-200306000-00005","volume":"27","author":"P Argani","year":"2003","unstructured":"Argani P, Lal P, Hutchinson B et al (2003) Aberrant nuclear immunoreactivity for TFE3 in neoplasms with TFE3 gene fusions: a sensitive and specific immunohistochemical assay. Am J Surg Pathol 27:750\u2013761","journal-title":"Am J Surg Pathol"},{"key":"792_CR25","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1038\/s41379-019-0283-z","volume":"32","author":"B Yang","year":"2019","unstructured":"Yang B, Duan H, Cao W et al (2019) Xp11 translocation renal cell carcinoma and clear cell renal cell carcinoma with TFE3 strong positive immunostaining: morphology, immunohistochemistry, and FISH analysis. Mod Pathol 32:1521\u20131535","journal-title":"Mod Pathol"},{"key":"792_CR26","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1097\/PAS.0b013e3181f17ac0","volume":"34","author":"P Argani","year":"2010","unstructured":"Argani P, Aulmann S, Illei PB et al (2010) A distinctive subset of PEComas harbors TFE3 gene fusions. Am J Surg Pathol 34:1395\u20131406","journal-title":"Am J Surg Pathol"},{"key":"792_CR27","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1038\/modpathol.2009.58","volume":"22","author":"G Martignoni","year":"2009","unstructured":"Martignoni G, Pea M, Gobbo S et al (2009) Cathepsin-K immunoreactivity distinguishes MiTF\/TFE family renal translocation carcinomas from other renal carcinomas. Mod Pathol 22:1016\u20131022","journal-title":"Mod Pathol"},{"key":"792_CR28","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1097\/PAS.0b013e31828a69ae","volume":"37","author":"WM Green","year":"2013","unstructured":"Green WM, Yonescu R, Morsberger L et al (2013) Utilization of a TFE3 break-apart FISH assay in a renal tumor consultation service. Am J Surg Pathol 37:1150\u20131163","journal-title":"Am J Surg Pathol"},{"key":"792_CR29","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1038\/s41379-018-0191-7","volume":"32","author":"J Pei","year":"2019","unstructured":"Pei J, Cooper H, Flieder DB et al (2019) NEAT1-TFE3 and KAT6A-TFE3 renal cell carcinomas, new members of MiT family translocation renal cell carcinoma. Mod Pathol 32:710\u2013716","journal-title":"Mod Pathol"},{"key":"792_CR30","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1097\/PDM.0b013e31820e9c67","volume":"20","author":"JM Mosquera","year":"2011","unstructured":"Mosquera JM, Dal Cin P, Mertz KD et al (2011) Validation of a TFE3 break-apart FISH assay for Xp11.2 translocation renal cell carcinomas. Diagn Mol Pathol 20:129\u2013137","journal-title":"Diagn Mol Pathol"},{"key":"792_CR31","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1097\/PAS.0b013e31818fbdff","volume":"33","author":"P Argani","year":"2009","unstructured":"Argani P, Aulmann S, Karanjawala Z et al (2009) Melanotic Xp11 translocation renal cancers: a distinctive neoplasm with overlapping features of PEComa, carcinoma, and melanoma. Am J Surg Pathol 33:609\u2013619","journal-title":"Am J Surg Pathol"},{"key":"792_CR32","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1007\/s12253-017-0200-z","volume":"23","author":"G Papp","year":"2017","unstructured":"Papp G, Nagy D, S\u00e1pi Z (2017) Unusual signal patterns of break-apart FISH probes used in the Diagnosis of Soft Tissue Sarcomas. Pathol Oncol Res 23:863\u2013871","journal-title":"Pathol Oncol Res"},{"key":"792_CR33","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1111\/his.13866","volume":"75","author":"I Kato","year":"2019","unstructured":"Kato I, Furuya M, Baba M et al (2019) RBM10-TFE3 renal cell carcinoma characterised by paracentric inversion with consistent closely split signals in break-apart fluorescence in-situ hybridisation: study of 10 cases and a literature review. Histopathology 75:254\u2013265","journal-title":"Histopathology"},{"key":"792_CR34","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1080\/00313020310001619901","volume":"35","author":"P Argani","year":"2003","unstructured":"Argani P, Ladanyi M (2003) Distinctive neoplasms characterised by specific chromosomal translocations comprise a significant proportion of the paediatric renal carcinomas. Pathology 35:492\u2013498","journal-title":"Pathology"},{"key":"792_CR35","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/S0165-4608(97)00063-0","volume":"101","author":"P Dal Cin","year":"1998","unstructured":"Dal Cin P, Stas M, Sciot R et al (1998) Translocation (X;1) reveals metastasis 31 years after renal cell carcinoma. Cancer Genet Cytogenet 101:58\u201361","journal-title":"Cancer Genet Cytogenet"},{"key":"792_CR36","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/S0165-4608(98)00181-2","volume":"110","author":"C Perot","year":"1999","unstructured":"Perot C, Bougaran J, Boccon-Gibod L et al (1999) Two new cases of papillary renal cell carcinoma with t(X;1)(p11;q21) in females. Cancer Genet Cytogenet 110:54\u201356","journal-title":"Cancer Genet Cytogenet"},{"key":"792_CR37","doi-asserted-by":"publisher","first-page":"178e3","DOI":"10.1016\/j.urology.2007.03.037","volume":"70","author":"S Rais-Bahrami","year":"2007","unstructured":"Rais-Bahrami S, Drabick JJ, De Marzo AM et al (2007) Xp11 translocation renal cell carcinoma: delayed but massive and lethal metastases of a chemotherapy-associated secondary malignancy. Urology 70:178e3\u2013178e6","journal-title":"Urology"},{"key":"792_CR38","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1186\/s12885-015-2031-1","volume":"15","author":"L Mangel","year":"2015","unstructured":"Mangel L, B\u00edr\u00f3 K, Batty\u00e1ni I et al (2015) A case study on the potential angiogenic effect of human chorionic gonadotropin hormone in rapid progression and spontaneous regression of metastatic renal cell carcinoma during pregnancy and after surgical abortion. BMC Cancer 15:1013","journal-title":"BMC Cancer"},{"key":"792_CR39","doi-asserted-by":"publisher","first-page":"2763","DOI":"10.1200\/JCO.2005.07.055","volume":"23","author":"JJ Patard","year":"2005","unstructured":"Patard JJ, Leray E, Rioux-Leclercq N et al (2005) Prognostic value of histologic subtypes in renal cell carcinoma: a multicenter experience. J Clin Oncol 23:2763\u20132771","journal-title":"J Clin Oncol"}],"container-title":["Pathology & Oncology Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12253-019-00792-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12253-019-00792-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12253-019-00792-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,22]],"date-time":"2021-02-22T19:55:34Z","timestamp":1614023734000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12253-019-00792-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,18]]},"references-count":39,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["792"],"URL":"https:\/\/doi.org\/10.1007\/s12253-019-00792-0","relation":{},"ISSN":["1219-4956","1532-2807"],"issn-type":[{"value":"1219-4956","type":"print"},{"value":"1532-2807","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,18]]},"assertion":[{"value":"30 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 December 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The study was ethically approved by the Medical Research Council of Hungary (174,894\/2017\/EKU). The renal carcinoma cases were retrospectively selected from the archives of the pathological institutions and informed consent was not obtained.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"The authors declare that they have no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}